Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
Marianne J. Rutten, Frederike Dijk, C. Dilara Savci-Heijink, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 300
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
Barbara Bassani, Denisa Baci, Matteo Gallazzi, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 461-461
Open Access | Times Cited: 141
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
Esther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
Debbie M. Ferns, A. Marijne Heeren, Sanne Samuels, et al.
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 61
Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
Nobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, et al.
Cancer Science (2020) Vol. 111, Iss. 8, pp. 3057-3070
Open Access | Times Cited: 46
Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma
Marta Szajnik, Malgorzata Czystowska, Esther Elishaev, et al.
Expert Review of Molecular Diagnostics (2016) Vol. 16, Iss. 8, pp. 811-826
Open Access | Times Cited: 40
Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer
Tasuku Mariya, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26806-26822
Open Access | Times Cited: 36
Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences
Elaheh Emadi, Fatemeh Akhoundi, Seyed Mehdi Kalantar, et al.
BMC Genomic Data (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 28
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Role of HLA-G in tumors and upon COVID-19 infection
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages
Chandra Kirana, Andrew Ruszkiewicz, Richard S. Stubbs, et al.
International Journal of Cancer (2017) Vol. 140, Iss. 11, pp. 2577-2586
Open Access | Times Cited: 31
Cancer treatment and the KIR–HLA system: an overview
Patrizia Leone, Vallì De Re, Angelo Vacca, et al.
Clinical and Experimental Medicine (2017) Vol. 17, Iss. 4, pp. 419-429
Closed Access | Times Cited: 29
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer
Esther Schwich, Vera Rebmann, Peter A. Horn, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1106-1106
Open Access | Times Cited: 27
Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma
Wafa Babay, Hamza Ben Yahia, Nadia Boujelbène, et al.
Human Immunology (2018) Vol. 79, Iss. 6, pp. 463-470
Closed Access | Times Cited: 26
Tumor border sharpness correlates with HLA-G expression in low-grade gliomas
Yinyan Wang, Xing Fan, Hongmin Li, et al.
Journal of Neuroimmunology (2015) Vol. 282, pp. 1-6
Closed Access | Times Cited: 25
EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma
Duc Vo, Yan Liu, Anil K. Sood, et al.
Cancer Biomarkers (2024) Vol. 39, Iss. 4, pp. 289-298
Open Access | Times Cited: 2
HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer.
Li Zhou, Zheyu Niu, Zhiyong Liang, et al.
PubMed (2015) Vol. 7, Iss. 10, pp. 2036-44
Closed Access | Times Cited: 22
Role of microRNAs on HLA-G expression in human tumors
Barbara Seliger
Human Immunology (2016) Vol. 77, Iss. 9, pp. 760-763
Closed Access | Times Cited: 22
HLA-G is upregulated in advanced endometriosis
Marici Rached Rached, Verônica Coelho, Maria Lúcia Carnevale Marin, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2019) Vol. 235, pp. 36-41
Closed Access | Times Cited: 21
A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
Ricky B. van de Water, Daniëlle Krijgsman, Ruben D. Houvast, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8265-8265
Open Access | Times Cited: 16
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top